NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE HEREOF NOR ANY INTEREST OR PARTICIPATION HEREIN OR THEREIN MAY BE SOLD, ASSIGNED, PLEDGED, HYPOTHECATED, ENCUMBERED OR IN ANY OTHER MANNER TRANSFERRED OR DISPOSED OF EXCEPT IN COMPLIANCE...Warrant Agreement • June 15th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
This certifies that, for good and valuable consideration,______________________________, a California corporation (the "Corporation"), grants to _______________________________________ or registered assigns (the "Warrantholder"), the right to subscribe for and purchase from the Corporation, at the price specified in subsection 2.1 hereof during the period specified in subsection 2.2 hereof, ______________________________________ validly issued, fully paid and non-assessable shares, as such number of shares may be adjusted from time to time (the "Warrant Shares"), of the Corporation's Common Stock, no par value (the "Common Stock"), subject to the provisions and upon the terms and conditions herein set forth.
FORM OF WARRANT TO PURCHASE COMMON STOCK OF ALLIANCE PHARMACEUTICAL CORP.Warrant Agreement • June 15th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
This certifies that, for good and valuable consideration received, ________________ and its registered, permitted assigns (collectively, the "Warrantholder"), are entitled to purchase from Alliance Pharmaceutical Corp., a corporation incorporated under the laws of New York (the "Company"), subject to the terms and conditions hereof, at any time on or after June 23, 1999 and before 5:00 P.M., New York time, on June 23, 2004, or such earlier date of expiration as may occur pursuant to Article VIII herein, (or, if such day is not a Business Day, as defined herein, at or before 5:00 P.M., New York time, on the next following Business Day), the number of fully paid and non-assessable shares of Common Stock (par value $.01) of the Company (the "Common Stock") stated above at the Exercise Price (as defined herein). The Exercise Price and the number of shares purchasable hereunder are subject to adjustment as provided in Article III hereof.
